APVO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Aptevo Therapeutics Inc (APVO) is not a strong buy for a beginner, long-term investor with $50,000-$100,000 available. The stock shows bearish technical indicators, weak financial performance, and no significant catalysts to drive growth. A hold position is recommended until clearer positive signals emerge.
The stock is showing bearish moving averages (SMA_200 > SMA_20 > SMA_5), with the RSI at 34.074 in the neutral zone. The MACD histogram is positive but contracting, and the price is trading below the pivot level of 6.864, closer to the support level of 6.138. This indicates a bearish trend with no clear reversal signals.
NULL. There are no recent news updates, no significant hedge fund or insider trading activity, and no recent congress trading data.
is also down by 1.54%, which reflects negative market sentiment. Financial performance is weak, with EPS dropping significantly (-99.38% YoY).
In Q3 2025, revenue remained at 0 with no growth. Net income improved by 76.98% YoY but remains negative at -$9,028,000. EPS dropped significantly to -40.13 (-99.38% YoY), and gross margin remains at 0. Overall, the company is not showing signs of financial growth or profitability.
No analyst rating or price target changes were provided. Wall Street sentiment is unclear, and there are no visible pros or cons from analysts.
